Treatment of striae alba with Pulsed dye laser and Fractional Co2 laser

Comprasion the Fractional Co2 laser and Pulsed Dye laser with Fractional Co2 laser alone in treatment of striae alba

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013123116013N1

Enrollment

Registered

2014-02-10

Start date

2012-11-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

striae. Striae atrophicae

Interventions

Intervention 1: On one hand can be treated with Fractional CO2 laser and Pulsed dye lasers in the intermittent sessions. A total of 5 sessions every two weeks (3 sessions Fractional carbon dioxide las

10600 nm

16±2 J/cm2 Pulsede dye laser: 585nm

Flu: 5-7 J/cm2

Spot size:7mm. Intervention 2: On the other hand was treated with 3 sessions with fractional carbon dioxide laser every four weeks. Fractional CO2 laser

16±2 J/cm2.

Treatment - Other

On the other hand was treated with 3 sessions with fractional carbon dioxide laser every four weeks. Fractional CO2 laser

16±2 J/cm2

On one hand can be treated with Fractional CO2 laser and Pulsed dye lasers in the intermittent sessions. A total of 5 sessions every two weeks (3 sessions Fractional carbon dioxide laser and 2 session

Spot size:7mm

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: striae alba found on the abdomen, hips, thighs and flanks; have not received any previous treatment for striae ; skin types 3 and 4 Exclusion criteria: pregnancy; lactation; stria alba on the chest and arms; previous treatment with medication or laser for striae; history of local or systemic steroid use; Cushing's syndrome or Ehlers-Danlos syndrome; use of isotretinoin or filler injections in 6 to 12 months Furthermore; performance of dermabrassion or laser skin rejuvenation in previous 6 to 12 months on striae

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
Severe erythema. Timepoint: After each session and every month. Method of measurement: clinical examination.;Hyperpigmentasion. Timepoint: after each session and every month. Method of measurement: clinical examination.;Edema. Timepoint: After each session and every month. Method of measurement: Clinical Examination.;Patient assessment. Timepoint: End of study. Method of measurement: Visual Analogue Scale(VAS).	—

Measure

Time frame

Severe erythema. Timepoint: After each session and every month. Method of measurement: clinical examination.;Hyperpigmentasion. Timepoint: after each session and every month. Method of measurement: clinical examination.;Edema. Timepoint: After each session and every month. Method of measurement: Clinical Examination.;Patient assessment. Timepoint: End of study. Method of measurement: Visual Analogue Scale(VAS).

—

Primary

Measure	Time frame
Striae Area. Timepoint: Baseline and two weeks after the end of laser therapy. Method of measurement: Pictzar software.;Striae Area. Timepoint: Baseline and after intervention. Method of measurement: 4- points scale by dermatologists who were not therapist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Nikyar

Skin and Leishmaniasis Research Center- Isfahan University of Medical Sciences

Z.nikyar@resident.mui.ac.ir+98 31 1268 3597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026